Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Lexington, Concord, and the Battle to Keep Government in Check
Low-Energy Fridays: What’s the deal with showerheads?
When the Trail Runs Cold: How Resource Gaps Leave Families Waiting
Antitrust Update: Big Tech Animus May Trump Consumer Welfare
Contraception Annual Supply: How to Implement Policy Successfully